Urso Alternatives Compared
| Urso (ursodiol) | Elafibranor | Seladelpar |
|
|---|
| Urso (ursodiol) | Elafibranor | Seladelpar |
|
|---|---|---|---|
|
Prescription only
Prescribed for Primary Biliary Cholangitis , Gallbladder Disease. Urso may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Primary Biliary Cholangitis . Elafibranor may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Primary Biliary Cholangitis . Seladelpar may also be used for purposes not listed in this medication guide. |
Related suggestions Primary Biliary Cholangitis
|
| More about Urso (ursodiol) | More about Elafibranor | More about Seladelpar | |
| Ratings & Reviews | |||
|
Urso has an average rating of 10.0 out of 10 from a total of 3 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||
|
View all Urso side effects |
View all Elafibranor side effects |
View all Seladelpar side effects |
|
| Drug Class | |||
| Generic Availability | |||
|
N/A |
N/A |
||
| Pricing and Coupons * Prices are without insurance | |||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | |||
|
N/A |
N/A |
|
| Brand Names | |||
| Other ursodiol brands include: Actigall, Reltone, Urso Forte | Iqirvo | Livdelzi | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||
|
139.2 hours |
92.2 hours |
6 hours |
|
| CSA Schedule 1 View glossary of CSA terms | |||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | |||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. |
|
| Drug Interactions | |||
|
A total of 7 drugs are known to interact with Urso:
|
A total of 241 drugs are known to interact with Elafibranor:
|
A total of 146 drugs are known to interact with Seladelpar:
|
|
| Alcohol/Food/Lifestyle Interactions | |||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
| Disease Interactions | |||
| First Approval Date | |||
|
December 10, 1997 |
June 10, 2024 |
August 14, 2024 |
|
| WADA Class View classifications | |||
|
N/A |
N/A |
N/A |
|
| More Information | |||
| Patient Resources | |||
| Professional Resources | |||
| Related Treatment Guide | |||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.